ZW10 interacting kinetochore protein (ZWINT), an essential part of the kinetochore complex, plays a crucial role in maintaining genome stability by correcting improper attachments between the kinetochore and microtubules. An initial analysis of The Cancer Genome Atlas and Gene Expression Omnibus databases revealed that ZWINT is significantly expressed across a diverse range of tumor types. We subsequently investigated the influence of ZWINT on clinical outcomes and potential signaling pathways. A multidimensional analysis of ZWINT revealed significant statistical associations between ZWINT expression and clinical outcomes, as well as the E2F1 oncogenic signature. Experimental validation confirmed the increased expression of ZWINT in both pancreatic cancer cell lines and pancreatic adenocarcinoma tissues. Furthermore, our findings indicate that ZWINT promotes the proliferation of PANC-1 cells through cell cycle regulation. This comprehensive analysis of ZWINT suggests a strong correlation between its expression and various types of tumors, especially pancreatic adenocarcinoma (PAAD), indicating its potential oncogenic role. These findings enhance our understanding of the function of ZWINT in carcinogenesis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839319 | PMC |
| http://dx.doi.org/10.62347/MDPI5698 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
High expression of H2AX/γ-H2AX is associated with distinct biological pathway alterations and shorter survival in oropharyngeal squamous cell carcinoma.
Oral Oncol
January 2025
Institute of Pathology, University Hospital of Cologne, University Cologne, Faculty of Medicine, Kerpener Strasse 62, 50937 Cologne, Germany. Electronic address:
Background: The histone gene H2AX and its phosphorylated protein γ-H2AX play a crucial role in the DNA damage response. This study investigates the expression of H2AX mRNA and its phosphorylated γ-H2AX protein in oropharyngeal squamous cell carcinoma (OPSCC), its association with distinct biological pathway alterations and its potential as a biomarker.
Materials And Methods: Expression of H2AX mRNA in 76 OPSCC from The Cancer Genome Atlas (TCGA) cohort was analyzed.
Identification of Tumor-Suppressive Controlled Genes: as a Therapeutic Target in Breast Cancer.
Noncoding RNA
November 2024
Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Our recently created RNA-sequence-based microRNA (miRNA) expression signature in breast cancer clinical specimens revealed that some family members were significantly downregulated in cancer tissues. Based on TCGA database analyses, we observed that among the family members, (the passenger strand derived from pre-) was significantly downregulated in breast cancer (BC) clinical specimens, and its low expression predicted worse prognoses. Ectopic expression assays showed that transfected cancer cells (MDA-MB-157 and MDA-MB-231) had their aggressive phenotypes significantly suppressed, e.
View Article and Find Full Text PDFIdentification of Diagnostic and Prognostic Subnetwork Biomarkers for Women with Breast Cancer Using Integrative Genomic and Network-Based Analysis.
Int J Mol Sci
November 2024
Molecular Oncology Department, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Breast cancer remains a major global health concern and a leading cause of cancer-related deaths among women. Early detection and effective treatment are essential in improving patient survival. Advances in omics technologies have provided deeper insights into the molecular mechanisms underlying breast cancer.
View Article and Find Full Text PDFDeciphering molecular landscape of breast cancer progression and insights from functional genomics and therapeutic explorations followed by in vitro validation.
Sci Rep
November 2024
Department of Biosciences, Jamia Millia Islamia, New Delhi, India.
Article Synopsis
- Breast cancer is caused by abnormal breast cells that can form tumors, which can spread and become deadly if not treated.
- The study aimed to understand the molecular changes from Ductal Carcinoma In Situ (DCIS) to Invasive Ductal Carcinoma (IDC) by identifying important hub genes related to this transition and potential treatments.
- Ten key hub genes linked to tumor progression were identified, with CDK1 and DTL being significant, and the study found that the anti-inflammatory compound Fisetin effectively binds to these genes, suggesting it could help in targeting treatment for breast cancer.
Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers.
Prostate Cancer Prostatic Dis
November 2024
Department of Urology, University of Duisburg-Essen, Essen, Germany.
Background: Localized prostate cancer (PCa) is a largely heterogeneous disease regarding its clinical behavior. Current risk stratification relies on clinicopathological parameters and distinguishing between indolent and aggressive cases remains challenging. To improve risk stratification, we aimed to identify new prognostic markers for PCa.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!